IRCCS Ospedale San Raffaele
IRCCS Ospedale San Raffaele
Milan, Italy47 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT05791201 | |
| Mild TBI in the Emergency Department | Disease Attributes, Emergencies, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Recruiting | Not stated | 2026-10-07 | NCT07021118 | |
| First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma | B-cell chronic lymphocytic leukemia, B-cell neoplasm, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, diffuse large B-cell lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-06 | NCT03625037 | |
| Regorafenib for Recurrent Meningioma (MIRAGE Trial) | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Nerve Tissue, central nervous system cancer, meningioma, neoplasm, nervous system disorder, tumor of meninges, vascular cancer | Recruiting | Phase 2 | 2026-09-30 | NCT06275919 | |
| A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne muscular dystrophy, Infant, Newborn, Diseases, Muscular Disorders, Atrophic, X-linked disease, congenital, hereditary disease, inherited neurodegenerative disorder, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, myotonic dystrophy, myotonic syndrome, nervous system disorder, neurodegenerative disease, neuromuscular disease | Recruiting | Phase 3 | 2026-09-29 | NCT07587242 | |
| Spectral and Ultra High Resolution CT Systems for Non-Invasive Detection of Myocardial Ischemia: Stress CT Perfusion VS. FFR-CT | CT Angiography; CT Perfusion; Coronary Arterial Disease (CAD); FFR-CT | Not yet recruiting | Not stated | 2026-09-21 | NCT07544277 | |
| Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab. | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Recruiting | Not stated | 2026-09-21 | NCT07330245 | |
| The Aim of the Study is to Characterize Patients Exhibiting Muscular Atrophy and Weakness Who Require a Muscle Biopsy for Diagnosis (IBM vs Atypical MND), Through an Innovative Technique Which Enables the Evaluation of the Neuromuscular Junction Involvement in Each Condition | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, inclusion body myositis, metabolic disease, motor neuron disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Active, not recruiting | Not stated | 2026-09-01 | NCT07796776 | |
| A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hypoglycemia, immune system disorder, metabolic disease, type 1 diabetes mellitus | Recruiting | Phase 3 | 2026-09-01 | NCT04786262 | |
| REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Recruiting | Not stated | 2026-08-25 | NCT06557798 | |
| Ibrutinib Plus Venetoclax Long-Term Outcomes in CLL | B-cell chronic lymphocytic leukemia, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Not stated | 2026-08-19 | NCT07774390 | |
| San Raffaele Registry on Liver Cancer | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, carcinoma of liver and intrahepatic biliary tract, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Not stated | 2026-07-15 | NCT07704489 | |
| Skeletal Muscle-derived Cell Implantation for Treatment of Fecal Incontinence | Digestive System Diseases, Fecal Incontinence, digestive system disorder, intestinal disorder, rectal disorder | Recruiting | Phase 3 | 2026-07-10 | NCT04976153 | |
| Emotional Distress in Patients With Metastatic Breast Cancer in First Line of Therapy | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not stated | 2026-06-17 | NCT06994377 | |
| Cera™ Vascular Plug System Post-Market Clinical Follow-Up | Aneurysm, Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Endoleak, Fistula, Hemorrhage, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Hemorrhage, Pulmonary Arteriovenous Fistulas, Vascular Fistula, arteriovenous hemangioma/malformation, cardiovascular disorder, congenital arteriovenous fistula, liver disorder, portal hypertension, vascular disorder, vascular malformation | Recruiting | Not stated | 2026-06-12 | NCT06099015 | |
| Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis | Adenomatous Polyps, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cronkhite-Canada syndrome, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, adenoma, classic familial adenomatous polyposis, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, hereditary disease, hereditary neoplastic syndrome, intestinal disorder, neoplasm, polyp | Recruiting | Phase 3 | 2026-06-02 | NCT06950385 | |
| A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Recruiting | Not applicable | 2026-06-01 | NCT07363044 | |
| A New Crowding Indicator in the Emergency Department | Disease Attributes, Emergencies, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Active, not recruiting | Not stated | 2026-05-20 | NCT07111624 | |
| GIM27-THERapy: a Study to Describe the Effectiveness of Tucatinib in Combination With Capecitabine and Trastuzumab in the Treatment of Metastatic HER-2 Positive Breast Cancer Patients in Real World Setting | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not stated | 2026-05-13 | NCT07583485 | |
| START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Adipose Tissue, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, connective tissue neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, liposarcoma, lung disorder, lung neoplasm, melanocytic neoplasm, melanoma, myxoid liposarcoma, neoplasm, neuroendocrine neoplasm, non-small cell lung carcinoma, osteosarcoma, primitive neuroectodermal tumor, rectal disorder, respiratory system disorder, respiratory tract neoplasm, sarcoma, skin disorder, skin neoplasm, synovial sarcoma, triple-negative breast carcinoma | Recruiting | Phase 1 | 2026-05-12 | NCT05492682 | |
| ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable) | metastatic prostate carcinoma | Recruiting | Phase 3 | 2026-04-28 | NCT04916613 | |
| FANS vs Standard Ureteral Access Sheath in fURS | Calculi, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Calculi, Male Urogenital Diseases, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Urinary Calculi, Urogenital Diseases, kidney disorder, nephrolithiasis, urinary system disorder, urolithiasis | Not yet recruiting | Not applicable | 2026-03-12 | NCT07463157 | |
| National Multicentre Study on Lipid Profile in Noonan Syndrome and Related Disorders: Trends by Age, Gender and Genotype | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Craniofacial Abnormalities, Musculoskeletal Abnormalities, Noonan syndrome, Skin and Connective Tissue Diseases, cardiovascular disorder, congenital heart disease, connective tissue disorder, heart disorder, musculoskeletal system disorder | Recruiting | Not stated | 2026-03-11 | NCT07464821 | |
| Study of SGR-1505 in Mature B-Cell Neoplasms | ALK-positive large B-cell lymphoma, B-cell chronic lymphocytic leukemia, B-cell neoplasm, Blood Protein Disorders, Burkitt lymphoma, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Leukemia, B-Cell, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, T-cell/histiocyte rich large B cell lymphoma, Tumor Virus Infections, Waldenstrom macroglobulinemia, cardiovascular disorder, diffuse large B-cell lymphoma, digestive system disorder, follicular lymphoma, hematologic disorder, hemorrhagic disease, high grade B-cell lymphoma, hypertrophic pyloric stenosis, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoplasmacytic lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, monoclonal gammopathy, neoplasm, neoplasm of mature B-cells, nodal marginal zone B-cell lymphoma, non-Hodgkin lymphoma, plasma cell neoplasm, plasmablastic lymphoma, primary cutaneous follicle center lymphoma, primary effusion lymphoma, pyloric stenosis, splenic marginal zone lymphoma, stomach disorder, vascular disorder, vascular hemostatic disease, viral infectious disease | Recruiting | Phase 1 | 2026-02-13 | NCT05544019 | |
| Italian Real-World Study of Epcoritamab in Relapsed or Refractory DLBCL | B-cell neoplasm, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Not stated | 2026-02-06 | NCT07393204 |